92
PERGUNTAS & RESPOSTAS
EMD
- Edema Macular Diabético
Referências
1. Sivaprasad S, Ockrim Z, Massaoutis P, et al. Posterior hyaloid changes following intra-
vitreal triamcinolone and macular laser for diffuse diabetic macular edema. Retina.
2008;28:1435-1442.
2. Hikichi T, Fujio N, Akiba J, Azuma Y, Takahashi M; Yoshida A:Association between the
short-term natural history of diabetic macular edema and the vitreomacular relationship
in type II diabetes mellitus. Ophthalmology. 1997;104(3);473-478.
3. Gundogan FC, Yolcu U, Akay F, Ilhan A, Ozge G, Uzun S. Pak J Diabetic Macular Ede-
ma. Med Sci. 2016 Mar-Apr;32(2):505-10.
4. The Diabetic Retinopathy Clinical Research Network: Vitrectomy outcomes in eyes with
diabetic macular edema and vitreomacular traction. Ophthalmology. 2010;117:1087-
1093.
5. The Diabetic Retinopathy Clinical Research Network:Factors Associated with Visual
acuity outcomes after vitrectomy for diabetic Macular Edema . Retina. 2010;30(9):1488-
1495.
6. Harbour JW, Smiddy WE, Flynn HW Jr, Rubsamen PE: Vitrectomy for diabetic macu-
lar edema associated with a thickened and taut posterior hyaloid membrane. Am J
Ophthalmol. 1996;121(4):405-13.
7. Pendergast SD, Hassan TS, Williams GA, Cox MS, Margherio RR, Ferrone PJ, Garretson
BR, Trese MT:Vitrectomy for diffuse diabetic macular edema associate with a taut pre-
macular posterior hyaloid. Am J Ophthalmol. 2000;130(2):178-86.
8. Gandorfer A, Messmer EM, Ulbig MW, Kampik A. Resolution of diabetic macular ede-
ma after surgical removal of the posterior hyaloid and the inner limiting membrane.
Retina. 2000;20(2);126-33.
9. Simunovic MP, Hunyor AP, Ho IV. Vitrectomy for diabetic macular edema: a systematic
review and meta-analysis. Can J Ophthalmol. 2014 Apr;49(2):188-95.
10. Jackson TL, Nicod E, Angelis A, Grimaccia F, Pringle E, Kanavos P. Pars plana vitrectomy
for diabetic macular edema: A Systematic Review, Meta-Analysis, and Synthesis of Safe-
ty Literature. Retina. 2017 May;37(5):886-895.
11. Browning DJ, Lee C, Stewart MW, Landers MD. Vitrectomy for center-involved diabetic
macular edema. Clin Ophthalmol. 2016 Apr 26;10:735-42.
12. Raizada S, Al Kandari J, Al Diab F, Al Sabah K, Kumar N, Mathew S. Pars plana vitrec-
tomy versus three intravitreal injections of bevacizumab for nontractional diabetic
macular edema. A prospective, randomized comparative study. Indian J Ophthalmol.
2015 Jun;63(6):504-10.
13. Ghassemi F, Bazvand F, Roohipoor R, Yaseri M, Hassanpoor N, Zarei M. Outcomes
of vitrectomy, membranectomy and internal limiting membrane peeling in patients
with refractory diabetic macular edema and non-tractional epiretinal membrane. J Curr
Ophthalmol. 2016 Aug 27;28(4):199-205.
14. Chablani JK, Kim JS, Cheng L, Kozak I, Freeman W. External limiting membrane as a
predictor of visual improvement in diabetic macular edema after pars plana vitrectomy.
Graefes Arch Clin Exp Ophthalmol. 2012;250:1415-1420.
15. Hirano T, Murata T. Vitrectomy for DME without macular traction. Retina Physician.
2013;10(6):6164.
16. Nascimento J, Lemos V, Henriques J. Role of ILM peeling in Diabetic Proliferative Reti-
nopathy with Exuberant Fibroglial Component, Oral presentation at the Vítreo-Retina




